Giuditta Gambino

Dr. Giuditta Gambino

Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), Section of Human Physiology University of Palermo.
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ANAndrea Navas-Olive
Andrea Navas-Olive
MVManuel Valero
Manuel Valero
TJTeresa Jurado-Parras
Teresa Jurado-Parras
ASAdan de Salas-Quiroga
Adan de Salas-Quiroga
RARobert G. Averkin
Robert G. Averkin
LPLiset M. de la Prida
Liset M. de la Prida
Theta oscillations play a major role in temporarily defining the hippocampal rate code by translating behavioral sequences into neuronal representations. However, mechanisms constraining phase timing and cell-type-specific phase preference are unknown. Here, we employ computational models tuned with evolutionary algorithms to evaluate phase preference of individual CA1 pyramidal cells recorded in mice and rats not engaged in any particular memory task. We applied unbiased and hypothesis-free approaches to identify effects of intrinsic and synaptic factors, as well as cell morphology, in determining phase preference. We found that perisomatic inhibition delivered by complementary populations of basket cells interacts with input pathways to shape phase-locked specificity of deep and superficial pyramidal cells. Somatodendritic integration of fluctuating glutamatergic inputs defined cycle-by-cycle by unsupervised methods demonstrated that firing selection is tuneable across sublayers. Our data identify different mechanisms of phase-locking selectivity that are instrumental for flexible dynamical representations of theta sequences.

8 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
DMDanila Di Majo
Danila Di Majo
FCFrancesco Cacciabaudo
Francesco Cacciabaudo
GAGiulia Accardi
Giulia Accardi
GGGiuditta Gambino
Giuditta Gambino
Giuseppe GigliaGiuseppe Giglia
Giuseppe Giglia
PSPierangelo Sardo
Pierangelo Sardo
Ketogenic Diet is a nutritional pattern often used as dietotherapy in inflammatory diseases, including neurological disorders. Applied on epileptic children since 1920, in recent years it has been taken into account again as a tool to both reduce inflammatory burdens and ameliorate the nutritional status of patients affected by different pathologies. Multiple sclerosis (MS) is considered an immune-mediated neuro-inflammatory disease and diet is a possible factor in its pathogenesis. The aim of this work is to investigate the main potential targets of MS-related impairments, in particular the cognitive deficits, focusing on the alteration of biomarkers such as the Brain Derived-Neurotrophic Factor and the Tryptophan/Kynurenine ratio that could play a role on neuroprotection and thus on MS progression. Furthermore, we here propose nutritional suggestions which are useful in the development of a ketogenic diet protocol that takes advantage of the anti-inflammatory properties of low-carbohydrate foods from the Mediterranean diet to be applied to subjects with MS. In conclusion, this approach will allow one to develop the ketogenic diet combined with a modified Mediterranean diet as a possible tool to improve neuroinflammation in multiple sclerosis.

13 August 2015 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Mario AllegraMario Allegra
Mario Allegra
FCFabio Carletti
Fabio Carletti
GGGiuditta Gambino
Giuditta Gambino
Marco TutoneMarco Tutone
Marco Tutone
AAAlessandro Attanzio
Alessandro Attanzio
Maria Antonia LivreaMaria Antonia Livrea
Maria Antonia Livrea

1 March 2014 in Behavioural Processes
Verified
Journal Article
Closed access
Fulvio PlesciaFulvio Plescia
Fulvio Plescia
RMRosa A.M. Marino
Rosa A.M. Marino
Michele NavarraMichele Navarra
Michele Navarra
GGGiuditta Gambino
Giuditta Gambino
ABAnna Brancato
Anna Brancato
CCCarla Cannizzaro
Carla Cannizzaro

1 December 2014 in Epilepsy Research
Verified
Journal Article
Closed access
VRValerio Rizzo
Valerio Rizzo
FCFabio Carletti
Fabio Carletti
GGGiuditta Gambino
Giuditta Gambino
GSGirolamo Schiera
Girolamo Schiera
CCCarla Cannizzaro
Carla Cannizzaro
PSPierangelo Sardo
Pierangelo Sardo

9 May 2018 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
GGGiuditta Gambino
Giuditta Gambino
Mario AllegraMario Allegra
Mario Allegra
PSPierangelo Sardo
Pierangelo Sardo
AAAlessandro Attanzio
Alessandro Attanzio
LTLuisa Tesoriere
Luisa Tesoriere
FCFabio Carletti
Fabio Carletti
Several studies have recently investigated the role of nutraceuticals in complex pathophysiological processes such as oxidative damages, inflammatory conditions and excitotoxicity. In this regard, the effects of nutraceuticals on basic functions of neuronal cells, such as excitability, are still poorly investigated. For this reason, the possible modulation of neuronal excitability by phytochemicals (PhC) could represent an interesting field of research given that excitotoxicity phenomena are involved in neurodegenerative alterations leading, for example, to Alzheimer’s disease. The present study was focused on indicaxanthin from Opuntia ficus indica, a bioactive betalain pigment, with a proven antioxidant and anti-inflammatory potential, previously found to cross blood-brain barrier (BBB) and to modulate the bioelectric activity of hippocampal neurons. On this basis, we aimed at detecting the specific brain areas where indicaxanthin localizes after oral administration at dietary-achievable amounts and highlighting eventual local effects on the excitability of single neuronal units. HPLC analysis of brain tissue 1 h after ingestion of 2 μmol/kg indicaxanthin indicated that the phytochemical accumulates in cortex, hippocampus, diencephalon, brainstem and cerebellum, but not in the striato-pallidal complex. Then, electrophysiological recordings, applying the microiontophoretic technique, were carried out with different amounts of indicaxanthin (0.34, 0.17, 0.085 ng/neuron) to assess whether indicaxanthin influenced the neuronal firing rate. The data showed that the bioelectric activity of neurons belonging to different brain areas was modulated after local injection of indicaxanthin, mainly with dose-related responses. A predominating inhibitory effect was observed, suggesting a possible novel beneficial effect of indicaxanthin in reducing cell excitability. These findings can constitute a new rationale for exploring biological mechanisms through which PhC could modulate neuronal function with a relapse on complex cognitive brain process and related neurodegenerative conditions.